Li Aifang, a member of the Party Leadership Group and Vice Chairperson of the Daxing District CPPCC, paid a visit to Minhai Biotechnology for inspection and guidance.

Release date:

2025-03-14

Author:

Source:


Abstract

Recently, Li Aifang, a member of the Party Leadership Group and Vice Chair of the CPPCC Committee of Daxing District, Beijing, paid a visit to Beijing Minhai Biotechnology Co., Ltd. to offer guidance. She toured the company’s corporate exhibition hall and its international‑standard vaccine industrial base, and engaged in an in-depth discussion with Zheng Haifa, a member of the Daxing District CPPCC Committee and General Manager of Minhai Biotechnology. Li Aifang emphasized that vaccines are a vital industry, delivering significant social, innovative, and economic value. For decades, Minhai Biotechnology has remained steadfastly committed to the research, development, and production of human vaccines, making outstanding contributions on behalf of Daxing District to the nation’s efforts in preventing and controlling infectious diseases. Looking ahead, she expressed the hope that the company will continue to take root in Daxing, expand globally, and bring greater benefits to public health through more high‑quality, highly effective, and innovative vaccines. She also urged the company to set an industry‑leading example in Daxing, thereby helping to drive the robust growth of the region’s biopharmaceutical sector.

Recently, Li Aifang, a member of the Party Leadership Group and Vice Chairperson of the Daxing District CPPCC in Beijing, paid a visit to Beijing Minhai Biotechnology Co., Ltd. to offer guidance. She toured the company’s corporate exhibition hall and the Internationalization Industrial Base for Novel Vaccines, and engaged in an in-depth exchange with Zheng Haifa, a member of the Daxing District CPPCC and General Manager of Minhai Biotechnology.

Li Aifang pointed out that vaccines are a vital industry, delivering social, innovative, and economic value. For decades, Minhai Biologics has remained steadfast in its commitment to the research, development, and production of human vaccines, earning recognition for the significant contributions it has made to China’s national infectious disease prevention and control efforts on behalf of Daxing District. Looking ahead, she expressed the hope that the company will continue to take root in Daxing, expand globally, and bring greater health benefits to the public through more high‑quality, highly effective, and innovative vaccines, while also setting an industry‑leading example in Daxing and helping to drive the robust growth of the region’s biopharmaceutical sector.

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09